99% Savings - Buy Just @1 Rs X
Cadinib is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Chronic Myelogenous Leukemia. Other than this, Cadinib has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Cadinib. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Cadinib have been listed ahead. Usually, these side effects of Cadinib go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Cadinib's effect is Severe during pregnancy and Moderate for lactating mothers. In addition, Cadinib's effects on the liver, heart and kidney are discussed below in the Cadinib related warnings section.
Other conditions have been mentioned below in the Cadinib contraindications section.
Drug interactions for Cadinib have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Cadinib, it is important to know that it is not safe while driving, and is not habit-forming.
Cadinib is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Cadinib safe for pregnant women?
Cadinib shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Cadinib safe during breastfeeding?
Breastfeeding women may feel side effects of Cadinib. If you see any side effects, stop taking Cadinib immediately and talk to your doctor. Take Cadinib again, only after your doctor's advice.
What is the effect of Cadinib on the Kidneys?
There may be some adverse effects on kidney after taking Cadinib. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Cadinib on the Liver?
Cadinib is rarely harmful for the liver.
What is the effect of Cadinib on the Heart?
You may experience side effects on your heart after taking Cadinib. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Cadinib should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cadinib unless your doctor advises you to do so -
Is this Cadinib habit forming or addictive?
Cadinib does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cadinib, you should not drive or work on any heavy machine, as Cadinib can make you drowsy.
Is it safe?
Yes, Cadinib is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Cadinib for mental disorders.
Interaction between Food and Cadinib
Taking Cadinib with food does not harm your health.
Interaction between Alcohol and Cadinib
Due to lack of research, there is no information about the side effects of taking Cadinib with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869